{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:02:49Z","timestamp":1769878969304,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["100933 and 182609"],"award-info":[{"award-number":["100933 and 182609"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["911946, 912051 and 912178"],"award-info":[{"award-number":["911946, 912051 and 912178"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Induction therapy of multiple myeloma patients prior to autologous stem cell transplantation has changed from conventional chemotherapy to treatment based on proteasome inhibitors or immunomodulatory drugs. We used flow cytometry to analyze total monocyte and monocyte subset (classical, intermediate and non-classical monocytes) peripheral blood levels before and following auto-transplantation for a consecutive group of myeloma patients who had received the presently used induction therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The patients showed normal total monocyte concentrations after induction\/stem cell mobilization, but the concentrations of classical monocytes were increased compared with healthy controls. Melphalan conditioning reduced the levels of total CD14<jats:sup>+<\/jats:sup> as well as classical and non-classical monocytes, whereas intermediate monocytes were not affected. Thus, melphalan has a non-random effect on monocyte subsets. Melphalan had a stronger effect on total and classical monocyte concentrations for those patients who had received induction therapy including immunomodulatory drugs. Total monocytes and monocyte subset concentrations decreased during the period of pancytopenia, but monocyte reconstitution occurred before hematopoietic reconstitution. However, the fractions of various monocyte subsets varied considerably between patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The total level of circulating monocytes is normalized early after auto-transplantation for multiple myeloma, but pre- and post-transplant levels of various monocyte subsets show considerable variation between patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12865-019-0323-y","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T15:27:31Z","timestamp":1573226851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Circulating monocyte subsets in multiple myeloma patients receiving autologous stem cell transplantation \u2013 a study of the preconditioning status and the course until posttransplant reconstitution for a consecutive group of patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Ida Marie","family":"Rundgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Ersv\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymen Bushra","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Ryningen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8ystein","family":"Bruserud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"issue":"12","key":"323_CR1","doi-asserted-by":"publisher","first-page":"E538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):E538\u2013E48.","journal-title":"Lancet Oncol"},{"issue":"1","key":"323_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21\u201333.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"323_CR3","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","volume":"97","author":"M Drayson","year":"2001","unstructured":"Drayson M, Tang LX, et al. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood. 2001;97(9):2900\u20132. \nhttps:\/\/doi.org\/10.1182\/blood.V97.9.2900\n\n.","journal-title":"Blood"},{"issue":"10","key":"323_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/ajh.23810","volume":"89","author":"S Vincent Rajkumar","year":"2014","unstructured":"Vincent Rajkumar S. Multiple myeloma: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89(10):999\u20131009. \nhttps:\/\/doi.org\/10.1002\/ajh.23810\n\n.","journal-title":"Am J Hematol"},{"issue":"1","key":"323_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","volume":"91","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;91(1):101\u201319. \nhttps:\/\/doi.org\/10.1016\/j.mayocp.2015.11.007\n\n.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"323_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1182\/blood.V92.5.1471","volume":"92","author":"T Guillaume","year":"1998","unstructured":"Guillaume T, Rubinstein DB, et al. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood. 1998;92(5):1471\u201390.","journal-title":"Blood"},{"issue":"5","key":"323_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.exphem.2016.01.002","volume":"44","author":"S Wichert","year":"2016","unstructured":"Wichert S, Pettersson A, et al. Phagocyte function decreases after high-dose treatment with melphalan and autologous stem cell transplantation in patients with multiple myeloma. Exp Hematol. 2016;44(5):342\u201351.e5. \nhttps:\/\/doi.org\/10.1016\/j.exphem.2016.01.002\n\n.","journal-title":"Exp Hematol"},{"key":"323_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/0-306-48382-3_20","volume":"528","author":"A Weinberger","year":"2003","unstructured":"Weinberger A, Klein T, et al. Clinical and genetic characteristics of late-onset Behcet\u2019s disease. Adv Exp Med Biol. 2003;528:99\u2013101. \nhttps:\/\/doi.org\/10.1007\/0-306-48382-3_20\n\n.","journal-title":"Adv Exp Med Biol"},{"issue":"5940","key":"323_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"FK Swirski","year":"2009","unstructured":"Swirski FK, Nahrendorf M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325(5940):612\u20136. \nhttps:\/\/doi.org\/10.1126\/science.1175202\n\n.","journal-title":"Science"},{"issue":"6","key":"323_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri.2017.28","volume":"17","author":"CV Jakubzick","year":"2017","unstructured":"Jakubzick CV, Randolph GJ, et al. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol. 2017;17(6):349\u201362. \nhttps:\/\/doi.org\/10.1038\/nri.2017.28\n\n.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"323_CR11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/jth.13751","volume":"15","author":"G. Arderiu","year":"2017","unstructured":"Arderiu G, Espinosa S, et al. Tissue factor variants induce monocyte transformation and transdifferentiation into endothelial cell-like cells. J Thromb Haemost. 2017. \nhttps:\/\/doi.org\/10.1111\/jth.13751\n\n.","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"32","key":"323_CR12","doi-asserted-by":"publisher","first-page":"53053","DOI":"10.18632\/oncotarget.18085","volume":"8","author":"F Costa","year":"2017","unstructured":"Costa F, Vescovini R, et al. Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties. Oncotarget. 2017;8(32):53053\u201367. \nhttps:\/\/doi.org\/10.18632\/oncotarget.18085\n\n.","journal-title":"Oncotarget"},{"issue":"7","key":"323_CR13","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood.V74.7.2527.2527","volume":"74","author":"B Passlick","year":"1989","unstructured":"Passlick B, Flieger D, et al. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood. 1989;74(7):2527\u201334.","journal-title":"Blood"},{"issue":"7","key":"323_CR14","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1084\/jem.20170355","volume":"214","author":"AA Patel","year":"2017","unstructured":"Patel AA, Zhang Y, et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med. 2017;214(7):1913\u201323. \nhttps:\/\/doi.org\/10.1084\/jem.20170355\n\n.","journal-title":"J Exp Med"},{"issue":"16","key":"323_CR15","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"L Ziegler-Heitbrock","year":"2010","unstructured":"Ziegler-Heitbrock L, Ancuta P, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74\u201380. \nhttps:\/\/doi.org\/10.1182\/blood-2010-02-258558\n\n.","journal-title":"Blood"},{"issue":"4","key":"323_CR16","doi-asserted-by":"publisher","first-page":"e0176460","DOI":"10.1371\/journal.pone.0176460","volume":"12","author":"LB Boyette","year":"2017","unstructured":"Boyette LB, Macedo C, et al. Phenotype, function, and differentiation potential of human monocyte subsets. PLoS One. 2017;12(4):e0176460. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0176460\n\n.","journal-title":"PLoS One"},{"issue":"13","key":"323_CR17","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","volume":"108","author":"N Giuliani","year":"2006","unstructured":"Giuliani N, Rizzoli V, et al. Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. Blood. 2006;108(13):3992\u20136. \nhttps:\/\/doi.org\/10.1182\/blood-2006-05-026112\n\n.","journal-title":"Blood"},{"issue":"1","key":"323_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/ijlh.12216","volume":"37","author":"V Petitprez","year":"2015","unstructured":"Petitprez V, Royer B, et al. CD14+ CD16+ monocytes rather than CD14+ CD51\/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study. Int J Lab Hematol. 2015;37(1):29\u201335. \nhttps:\/\/doi.org\/10.1111\/ijlh.12216\n\n.","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"323_CR19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/leu.2013.385","volume":"28","author":"R Silbermann","year":"2014","unstructured":"Silbermann R, Bolzoni M, et al. Bone marrow monocyte\u2212\/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma. Leukemia. 2014;28(4):951\u20134. \nhttps:\/\/doi.org\/10.1038\/leu.2013.385\n\n.","journal-title":"Leukemia"},{"issue":"4","key":"323_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3324\/haematol.2016.153841","volume":"102","author":"M Bolzoni","year":"2017","unstructured":"Bolzoni M, Ronchetti D, et al. IL21R expressing CD14(+)CD16(+) monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102(4):773\u201384. \nhttps:\/\/doi.org\/10.3324\/haematol.2016.153841\n\n.","journal-title":"Haematologica"},{"issue":"4","key":"323_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.clinthera.2015.01.008","volume":"37","author":"S Bekkering","year":"2015","unstructured":"Bekkering S, Joosten LAB, et al. The Epigenetic Memory of Monocytes and Macrophages as a Novel Drug Target in Atherosclerosis. Clin Ther. 2015;37(4):914\u201323. \nhttps:\/\/doi.org\/10.1016\/j.clinthera.2015.01.008\n\n.","journal-title":"Clin Ther"},{"issue":"4","key":"323_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.smim.2016.05.003","volume":"28","author":"MA Hamon","year":"2016","unstructured":"Hamon MA, Quintin J. Innate immune memory in mammals. Semin Immunol. 2016;28(4):351\u20138. \nhttps:\/\/doi.org\/10.1016\/j.smim.2016.05.003\n\n.","journal-title":"Semin Immunol"},{"issue":"2","key":"323_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","volume":"12","author":"J Quintin","year":"2012","unstructured":"Quintin J, Saeed S, et al. Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes. Cell Host Microbe. 2012;12(2):223\u201332. \nhttps:\/\/doi.org\/10.1016\/j.chom.2012.06.006\n\n.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"323_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3324\/haematol.2014.113217","volume":"100","author":"S Fiorcari","year":"2015","unstructured":"Fiorcari S, Martinelli S, et al. Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. Haematologica. 2015;100(2):253\u201362. \nhttps:\/\/doi.org\/10.3324\/haematol.2014.113217\n\n.","journal-title":"Haematologica"},{"issue":"7","key":"323_CR25","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bbmt.2015.03.002","volume":"21","author":"N Shah","year":"2015","unstructured":"Shah N, Callander N, et al. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Tr. 2015;21(7):1155\u201366. \nhttps:\/\/doi.org\/10.1016\/j.bbmt.2015.03.002\n\n.","journal-title":"Biol Blood Marrow Tr"},{"issue":"6","key":"323_CR26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/sj.leu.2403341","volume":"18","author":"LF Porrata","year":"2004","unstructured":"Porrata LF, Gertz MA, et al. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia. 2004;18(6):1085\u201392. \nhttps:\/\/doi.org\/10.1038\/sj.leu.2403341\n\n.","journal-title":"Leukemia"},{"issue":"6","key":"323_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/1042819031000077089","volume":"44","author":"LF Porrata","year":"2003","unstructured":"Porrata LF, Gastineau DA, et al. Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation. Leukemia Lymphoma. 2003;44(6):997\u20131000. \nhttps:\/\/doi.org\/10.1080\/1042819031000077089\n\n.","journal-title":"Leukemia Lymphoma"},{"issue":"3","key":"323_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1182\/blood.V98.3.579","volume":"98","author":"LF Porrata","year":"2001","unstructured":"Porrata LF, Gertz MA, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood. 2001;98(3):579\u201385. \nhttps:\/\/doi.org\/10.1182\/blood.V98.3.579\n\n.","journal-title":"Blood"},{"issue":"6","key":"323_CR29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bbmt.2014.03.007","volume":"20","author":"J Rueff","year":"2014","unstructured":"Rueff J, Medinger M, et al. Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma. Biol Blood Marrow Transplant. 2014;20(6):896\u20139. \nhttps:\/\/doi.org\/10.1016\/j.bbmt.2014.03.007\n\n.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"323_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11306-016-1139-x","volume":"13","author":"KJ Hatfield","year":"2017","unstructured":"Hatfield KJ, Melve GK, et al. Granulocyte colony-stimulating factor alters the systemic metabolomic profile in healthy donors. Metabolomics. 2017;13(1):2. \nhttps:\/\/doi.org\/10.1007\/s11306-016-1139-x\n\n.","journal-title":"Metabolomics"},{"key":"323_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3389\/fimmu.2018.00845","volume":"9","author":"GK Melve","year":"2018","unstructured":"Melve GK, Ersvaer E, et al. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets. Front Immunol. 2018;9:845. \nhttps:\/\/doi.org\/10.3389\/fimmu.2018.00845\n\n.","journal-title":"Front Immunol"},{"key":"323_CR32","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3389\/fimmu.2016.00523","volume":"7","author":"U Impola","year":"2016","unstructured":"Impola U, Larjo A, et al. Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML. Front Immunol. 2016;7:523. \nhttps:\/\/doi.org\/10.3389\/fimmu.2016.00523\n\n.","journal-title":"Front Immunol"},{"issue":"8","key":"323_CR33","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/j.1365-2362.2012.02656.x","volume":"42","author":"E Shantsila","year":"2012","unstructured":"Shantsila E, Tapp LD, et al. The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates. Eur J Clin Invest. 2012;42(8):832\u20139. \nhttps:\/\/doi.org\/10.1111\/j.1365-2362.2012.02656.x\n\n.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"323_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ajcp\/69.1.48","volume":"69","author":"BE Statland","year":"1978","unstructured":"Statland BE, Winkel P, et al. Evaluation of Biologic Sources of Variation of Leukocyte Counts and Other Hematologic Quantities Using Very Precise Automated Analyzers. Am J Clin Pathol. 1978;69(1):48\u201354.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"323_CR35","first-page":"31","volume":"11","author":"AM Saunders","year":"1985","unstructured":"Saunders AM. Sources of physiological variation in differential leukocyte counting. Blood Cells. 1985;11(1):31\u201348.","journal-title":"Blood Cells"},{"issue":"1","key":"323_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1081\/Cbi-120002594","volume":"19","author":"R Smaaland","year":"2002","unstructured":"Smaaland R, Sothern RB, et al. Rhythms in human bone marrow and blood cells. Chronobiol Int. 2002;19(1):101\u201327. \nhttps:\/\/doi.org\/10.1081\/Cbi-120002594\n\n.","journal-title":"Chronobiol Int"},{"key":"323_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jim.2018.06.003","volume":"461","author":"IM Rundgren","year":"2018","unstructured":"Rundgren IM, Bruserud O, et al. Standardization of sampling and sample preparation for analysis of human monocyte subsets in peripheral blood. J Immunol Methods. 2018;461:53\u201362. \nhttps:\/\/doi.org\/10.1016\/j.jim.2018.06.003\n\n.","journal-title":"J Immunol Methods"},{"issue":"21","key":"323_CR38","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1182\/blood.V122.21.2126.2126","volume":"122","author":"NS Callander","year":"2013","unstructured":"Callander NS, Rathouz PJ, et al. Recovery Of Natural Killer Cells and Monocyte Subsets Following Autologous Peripheral Blood Stem Cell Transplantation Predicts Longer Progression Free Survival Among Multiple Myeloma Patients. Blood. 2013;122(21):2126.","journal-title":"Blood"},{"issue":"1\u20133","key":"323_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12026-014-8528-x","volume":"59","author":"TR Rosean","year":"2014","unstructured":"Rosean TR, Tompkins VS, et al. Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma. Immunol Res. 2014;59(1\u20133):188\u2013202. \nhttps:\/\/doi.org\/10.1007\/s12026-014-8528-x\n\n.","journal-title":"Immunol Res"},{"issue":"3","key":"323_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1084\/jem.20110132","volume":"208","author":"A Ehninger","year":"2011","unstructured":"Ehninger A, Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med. 2011;208(3):421\u20138. \nhttps:\/\/doi.org\/10.1084\/jem.20110132\n\n.","journal-title":"J Exp Med"},{"issue":"4","key":"323_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clml.2014.02.001","volume":"14","author":"S Fleming","year":"2014","unstructured":"Fleming S, Harrison SJ, et al. The Choice of Multiple Myeloma Induction Therapy Affects the Frequency and Severity of Oral Mucositis After Melphalan-Based Autologous Stem Cell Transplantation. Cl Lymph Myelom Leuk. 2014;14(4):291\u20136. \nhttps:\/\/doi.org\/10.1016\/j.clml.2014.02.001\n\n.","journal-title":"Cl Lymph Myelom Leuk"},{"issue":"1","key":"323_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.6004\/jnccn.2013.0005","volume":"11","author":"S Lonial","year":"2013","unstructured":"Lonial S, San Miguel JF. Induction Therapy for Newly Diagnosed Multiple Myeloma. J Natl Compr Canc Ne. 2013;11(1):19\u201328. \nhttps:\/\/doi.org\/10.6004\/jnccn.2013.0005\n\n.","journal-title":"J Natl Compr Canc Ne"},{"issue":"2","key":"323_CR43","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1016\/j.bbmt.2014.11.239","volume":"21","author":"B Dhakal","year":"2015","unstructured":"Dhakal B, Brazauskas R, et al. Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Tr. 2015;21(2):S163\u2013S4. \nhttps:\/\/doi.org\/10.1016\/j.bbmt.2014.11.239\n\n.","journal-title":"Biol Blood Marrow Tr"},{"issue":"7","key":"323_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/CJI.0000000000000182","volume":"40","author":"S Vasileiou","year":"2017","unstructured":"Vasileiou S, Baltadakis I, et al. Ex Vivo Induction of Multiple Myeloma-specific Immune Responses by Monocyte-derived Dendritic Cells Following Stimulation by Whole-tumor Antigen of Autologous Myeloma Cells. J Immunother. 2017;40(7):253\u201364.","journal-title":"J Immunother"},{"issue":"22","key":"323_CR45","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1158\/1078-0432.Ccr-16-0866","volume":"22","author":"O Landgren","year":"2016","unstructured":"Landgren O, Rajkumar SV. New developments in diagnosis, prognosis, and assessment of response in multiple myeloma. Clin Cancer Res. 2016;22(22):5428\u201333. \nhttps:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-0866\n\n.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"323_CR46","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.14827","volume":"178","author":"A Chantry","year":"2017","unstructured":"Chantry A, Kazmi M, et al. Guidelines for the use of imaging in the management of patients with myeloma. Brit J Haematol. 2017;178(3):380\u201393. \nhttps:\/\/doi.org\/10.1111\/bjh.14827\n\n.","journal-title":"Brit J Haematol"},{"issue":"7","key":"323_CR47","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jcyt.2013.02.008","volume":"15","author":"KA Mosevoll","year":"2013","unstructured":"Mosevoll KA, Akkok CA, et al. Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 2013;15(7):850\u201360. \nhttps:\/\/doi.org\/10.1016\/j.jcyt.2013.02.008\n\n.","journal-title":"Cytotherapy"},{"issue":"10","key":"323_CR48","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3109\/14653249.2011.605117","volume":"13","author":"CA Akkok","year":"2011","unstructured":"Akkok CA, Hervig T, et al. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 2011;13(10):1259\u201368. \nhttps:\/\/doi.org\/10.3109\/14653249.2011.605117\n\n.","journal-title":"Cytotherapy"},{"issue":"3","key":"323_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/152581603322023089","volume":"12","author":"AM Bakken","year":"2003","unstructured":"Bakken AM, Bruserud O, et al. No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematoth Stem Cell. 2003;12(3):351\u20138. \nhttps:\/\/doi.org\/10.1089\/152581603322023089\n\n.","journal-title":"J Hematoth Stem Cell"},{"issue":"5","key":"323_CR50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1537-2995.2004.03336.x","volume":"44","author":"JF Abrahamsen","year":"2004","unstructured":"Abrahamsen JF, Rusten L, et al. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Transfusion. 2004;44(5):785\u20139. \nhttps:\/\/doi.org\/10.1111\/j.1537-2995.2004.03336.x\n\n.","journal-title":"Transfusion"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-019-0323-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-019-0323-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-019-0323-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:18:36Z","timestamp":1604708316000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-019-0323-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1186\/s12865-019-0323-y","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"assertion":[{"value":"17 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the Declaration of Helsinki. Collection of patient samples and the use of these samples in the present study were approved by the Regional Ethics Committee. Samples were collected and stored after written informed consent (REK Vest 2015\/1759), and the use of biological material and the present project was also approved by the committee (REF Vest 2017\/305, 2013\/102). The normal controls were healthy blood donors; in accordance with the approved routines at the Blood Bank, Haukeland University Hospital, peripheral venous blood samples for medical research were donated after written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}